Davita INC 10-Q quarterly reports

DaVita Inc. announced robust financial results for the second quarter of 2026, showcasing significant revenue increases and improved operating income.

DaVita reported Q1 2026 net income of $275 million, driven by steady dialysis patient service revenues and operational efficiencies.

DaVita Inc. reported a significant drop in net income and diluted EPS for the third quarter and year-to-date periods, impacted by increased operating expenses, higher debt costs, and a cybersecurity incident.

DaVita Inc. reports increased total revenues for Q2 2025 and year-to-date, alongside higher debt and ongoing impacts from a recent cybersecurity incident.

DaVita Inc.'s Q1 2025 results reflect the impact of a cybersecurity incident and a severe flu season, alongside strategic financial maneuvers including share repurchases and debt management.

DaVita Inc. reports its third quarter 2024 financial results, showing revenue growth and strategic adjustments amid ongoing economic and industry challenges.

DaVita Inc.'s second quarter results were impacted by the Change Healthcare cyberattack, which caused billing and collection delays, but the company also saw growth in treatment volumes and revenue per treatment.

DaVita Inc. announced its first quarter 2024 results, showing increased revenue and operating income, despite challenges from a cybersecurity incident at Change Healthcare.